Journal of Clinical Pharmacy and Therapeutics

Wiley (Blackwell Publishing)

http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2710

https://onlinelibrary.wiley.com/journal/13652710

Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis

bright archive

Anji Xiong, Yuzi Cao, Qilang Xiang, Zhuoyao Song, Yan Zhang, Shifeng Zhou, Yiying Qiang, Huini Chen, Ziyi Hu, Hongxu Cui, Jie Luo, Ye Wang (+3 others)

2022 | Journal of Clinical Pharmacy and Therapeutics
doi:10.1111/jcpt.13621 pmid:35233779

Maintained P2Y <sub>12</sub> inhibitor monotherapy after shorter‐duration of dual antiplatelet therapy in patients undergoing coronary drug‐eluting stents implantation: An updated meta‐analysis of randomized trials

bright archive

Zhong‐guo Fan, Nai‐Liang Tian, Sheng‐Hu He, Gen‐Shan Ma

2022 | Journal of Clinical Pharmacy and Therapeutics
doi:10.1111/jcpt.13626 pmid:35218029

Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS‐mutant metastatic colorectal cancer

bright archive

Weizhen Huang, Hang Zhang, Yunming Tian, Yinlian Cha, Hailin Xiong, Xia Yuan

2022 | Journal of Clinical Pharmacy and Therapeutics
doi:10.1111/jcpt.13576 pmcid:PMC9306912

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

bright archive

Erin Milner, Michael Ainsworth, Melinda Gleaton, David Bookstaver

2022 | Journal of Clinical Pharmacy and Therapeutics
doi:10.1111/jcpt.13596 pmcid:PMC9305439

Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission

bright archive

Kathrin Golla, Hanna Mannell, Andreas Benesic, Tobias Dreischulte, Eva Grill, Dorothea Strobach

2022 | Journal of Clinical Pharmacy and Therapeutics
doi:10.1111/jcpt.13597 pmid:35014073

4,101

Known Releases

Preservation Summary [more]

	215	preserved and accessble (bright)
	3,886	preserved, inaccessible (dark)
	0	no known preservation

Release Types

`article-journal`	4,073
unknown-type	25
`editorial`	2
`letter`	1

Publication Type journal
Country Code gb

ISSN-L^? 0269-4727
Print: 0269-4727
Electronic: 1365-2710
Wikidata Q15753553
archive.org sim_pubid:15530

Directory Listings
Not in DOAJ

Lookup Links

ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)

Catalog Record
Revision: 2feb0fc3-d3a0-406e-9382-80b46dbfcdac
API URL: JSON

Edit Metadata View History

Journal of Clinical Pharmacy and Therapeutics `container_cjteyer36vdehdrd24h5vtobta`

Homepage URLs

Example Publications

Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis

Maintained P2Y <sub>12</sub> inhibitor monotherapy after shorter‐duration of dual antiplatelet therapy in patients undergoing coronary drug‐eluting stents implantation: An updated meta‐analysis of randomized trials

Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS‐mutant metastatic colorectal cancer

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission

Journal of Clinical Pharmacy and Therapeutics container_cjteyer36vdehdrd24h5vtobta

Homepage URLs

Example Publications

Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis

Maintained P2Y <sub>12</sub> inhibitor monotherapy after shorter‐duration of dual antiplatelet therapy in patients undergoing coronary drug‐eluting stents implantation: An updated meta‐analysis of randomized trials

Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS‐mutant metastatic colorectal cancer

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission

Journal of Clinical Pharmacy and Therapeutics `container_cjteyer36vdehdrd24h5vtobta`